8-KEarnings & ResultsExhibits & Filings

IDEXX LABORATORIES INC /DE 8-K Report, Financial Results (Jan 27, 2012)

Filed January 27, 2012For Securities:IDXX

Summary

This 8-K filing from IDEXX Laboratories, Inc. (IDXX) on January 27, 2012, announces their financial results for the fourth quarter and full year ended December 31, 2011. The core of this report is the furnished press release (Exhibit 99.1), which contains the detailed financial performance data. Investors should refer to this press release for specific figures, as this 8-K primarily serves as a notification of the earnings release. The filing is important for understanding IDEXX's financial standing at the close of 2011. While the 8-K itself doesn't provide the numbers, it directs investors to the official source of this crucial information. The Chief Financial Officer, Merilee Raines, signed off on the report, underscoring the official nature of the announced results.

Key Highlights

  • 1IDEXX Laboratories announced its financial results for the fourth quarter and full year ended December 31, 2011.
  • 2The press release containing the detailed financial results is furnished as Exhibit 99.1 to the 8-K.
  • 3The filing is dated January 27, 2012, coinciding with the press release date.
  • 4The report is filed under Item 2.02 (Results of Operations and Financial Condition).
  • 5Information furnished under Item 2.02 is generally not deemed 'filed' for certain SEC liability purposes.
  • 6The Chief Financial Officer, Merilee Raines, signed the report.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially announce and provide access to IDEXX Laboratories' financial results for the fourth quarter and the full fiscal year ended December 31, 2011. The detailed financial information is contained within an attached press release.

The specific financial results are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should consult this press release for quantitative data on revenue, earnings, and other key financial metrics.

Under SEC rules, information furnished under Item 2.02 of Form 8-K, such as earnings releases, is generally not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means the company may have less liability for inaccuracies in that specific furnished information compared to information that is formally 'filed'.

The report was signed by Merilee Raines, who held the positions of Corporate Vice President, Chief Financial Officer, and Treasurer at IDEXX Laboratories, Inc.